Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
If proven safe and effective, these patches may offer a more convenient, less invasive option for people who use GLP-1 medications in the future.
Tirzepatide is still at 2.5mg, its sub-therapeutic starting dose, and hasn't reached the levels that drive meaningful appetite suppression
Stay at current dose until eating improves enough to meet minimums
During the preparation of this work, the authors used AI tools including Grammarly and Overleaf AI Assist for scientific writing
Research suggests that individuals with BED may be at a higher risk of developing type 2 diabetes due to the potential weight gain resulting from binge eating behaviors
dose escalation may take up to 8 weeks: Week 1: Inject 0.6 mg subcutaneously once a day Week 2: Inject 1.2 mg subcutaneously once a day Week 3: Inject 1.8 mg subcutaneously once a day Week 4: Inject 2.4 mg subcutaneously once a day Week 5: Inject 3 mg subcutaneously once a day Maintenance dose : 2.4 or 3 mg subcutaneously once a day If maintenance dose is not tolerated, discontinuation is recommended
